SWISS RE LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89 EUR | +0.23% |
|
-.--% | -.--% |
| 05-03 | SWISS REINSURANCE COMPANY : Gets a Neutral rating from Barclays | ZD |
| 04-22 | Swiss Re to Roll Out AI-Powered Insurance Underwriting Assistant | MT |
| Sales 2024 * | 48.32B 44.87B 3,859B | Sales 2025 * | 50B 46.43B 3,993B | Capitalization | 33.96B 31.54B 2,712B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.73B 3.46B 298B | Net income 2025 * | 4.05B 3.76B 323B | EV / Sales 2024 * | 0.8 x |
| Net Debt 2024 * | 4.6B 4.27B 367B | Net Debt 2025 * | 4.61B 4.28B 368B | EV / Sales 2025 * | 0.77 x |
| P/E ratio 2024 * |
9.23
x | P/E ratio 2025 * |
8.44
x | Employees | 14,719 |
| Yield 2024 * |
6.19% | Yield 2025 * |
6.57% | Free-Float | 91.32% |
More Fundamentals
* Assessed data
More news
Latest transcript on Swiss Re Ltd
More recommendations
More press releases
| 1 day | +0.23% |
5 years
78.96
90.48
10 years
57.2193.85
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 30/06/16 | |
John Dacey
DFI | Director of Finance/CFO | 64 | 30/09/12 |
Velina Peneva
CIO | Chief Investment Officer | - | 31/12/16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Larry Zimpleman
BRD | Director/Board Member | 72 | 19/04/18 |
| Director/Board Member | 68 | 20/04/17 | |
| Chairman | 63 | 20/04/17 |
Swiss Re Ltd is one of the world's leading reinsurance groups. Earned premiums break down by activity as follows:
- non-life reinsurance (51.6%): primarily damage, civil liability, automobile, accident, credit and guarantee, and other types of reinsurance;
- life and health reinsurance (34.7%; No. 1 worldwide): primarily life (69.2% of earned premiums) and health (30.8%);
- financial services (12.6%): asset management, investment capital, financial consulting, sales of structured products, etc.;
- others (1.1%).
Sector
Reinsurance
Calendar
15/05/2024
- Q1 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
117
USD
Average target price
121.4
USD
Spread / Average Target
+3.83%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.37% | 6.75B | |
| +9.54% | 6.43B | |
| +4.90% | 4.53B | |
| +12.87% | 868M | |
| +23.43% | 701M | |
| +9.29% | 507M | |
| +103.28% | 410M | |
| +7.56% | 158M | |
| +8.20% | 152M |
- Stock Market
- Equities
- SREN Stock
- SR9 Stock
